| |
Discovery of Bictegravir (GS-9883), a Novel, Unboosted, Once-Daily HIV-1 Integrase Strand Transfer Inhibitor (INSTI) with Improved Pharmacokinetics and In Vitro Resistance Profile
|
| |
| |
Reported by Jules Levin
ASM Microbe, June 16-20, 2016, Boston, MA
SE Lazerwith, R Cai, X Chen, G Chin, MC Desai, S Eng, R Jacques, M Ji, G Jones, H Martin, C McMahon, M Mish, P Morganelli, J Mwangi, H-J Pyun, U Schmitz, G Stepan, J Szwarcberg, J Tang, M Tsiang, J Wang, K Wang, K White, L Wiser, J Zack, H JinGilead Sciences, Foster City, CA
|
|
| |
| |
|
|
|
